Global Edaravone Injection Market Growth 2025-2031

December 2025 | 82 pages | ID: G437130C99B3EN
LP Information

Abstracts

The global Edaravone Injection market size is predicted to grow from US$ 325 million in 2025 to US$ 588 million in 2031; it is expected to grow at a CAGR of 10.4% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Edaravone, sold as under the brand names Radicava and Radicut, is an intravenous medication used to help with recovery following a stroke[1] and to treat amyotrophic lateral sclerosis (ALS).

The Radicava market is driven by the need for effective treatments for amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disease. Radicava, containing edaravone, is an intravenous medication that has been shown to slow the decline in physical function in ALS patients. The drug's approval and positive clinical outcomes have led to its increasing adoption in ALS management. However, challenges include the high cost of the medication, the need for ongoing treatment, and access barriers in certain regions. Overcoming these challenges through affordability measures, patient support programs, and continued research to better understand and treat ALS will be crucial for the sustained growth of the Radicava market.

LP Information, Inc. (LPI) ' newest research report, the “Edaravone Injection Industry Forecast” looks at past sales and reviews total world Edaravone Injection sales in 2024, providing a comprehensive analysis by region and market sector of projected Edaravone Injection sales for 2025 through 2031. With Edaravone Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Edaravone Injection industry.

This Insight Report provides a comprehensive analysis of the global Edaravone Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Edaravone Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Edaravone Injection market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Edaravone Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Edaravone Injection.

This report presents a comprehensive overview, market shares, and growth opportunities of Edaravone Injection market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• 20ml
• 100ml

Segmentation by Application:

• Hospital
• Pharmacy

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Mitsubishi Tanabe Pharma

Key Questions Addressed in this Report

What is the 10-year outlook for the global Edaravone Injection market?

What factors are driving Edaravone Injection market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Edaravone Injection market opportunities vary by end market size?

How does Edaravone Injection break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Edaravone Injection Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Edaravone Injection by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Edaravone Injection by Country/Region, 2020, 2024 & 2031
2.2 Edaravone Injection Segment by Type
  2.2.1 20ml
  2.2.2 100ml
2.3 Edaravone Injection Sales by Type
  2.3.1 Global Edaravone Injection Sales Market Share by Type (2020-2025)
  2.3.2 Global Edaravone Injection Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Edaravone Injection Sale Price by Type (2020-2025)
2.4 Edaravone Injection Segment by Application
  2.4.1 Hospital
  2.4.2 Pharmacy
2.5 Edaravone Injection Sales by Application
  2.5.1 Global Edaravone Injection Sale Market Share by Application (2020-2025)
  2.5.2 Global Edaravone Injection Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Edaravone Injection Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Edaravone Injection Breakdown Data by Company
  3.1.1 Global Edaravone Injection Annual Sales by Company (2020-2025)
  3.1.2 Global Edaravone Injection Sales Market Share by Company (2020-2025)
3.2 Global Edaravone Injection Annual Revenue by Company (2020-2025)
  3.2.1 Global Edaravone Injection Revenue by Company (2020-2025)
  3.2.2 Global Edaravone Injection Revenue Market Share by Company (2020-2025)
3.3 Global Edaravone Injection Sale Price by Company
3.4 Key Manufacturers Edaravone Injection Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Edaravone Injection Product Location Distribution
  3.4.2 Players Edaravone Injection Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR EDARAVONE INJECTION BY GEOGRAPHIC REGION

4.1 World Historic Edaravone Injection Market Size by Geographic Region (2020-2025)
  4.1.1 Global Edaravone Injection Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Edaravone Injection Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Edaravone Injection Market Size by Country/Region (2020-2025)
  4.2.1 Global Edaravone Injection Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Edaravone Injection Annual Revenue by Country/Region (2020-2025)
4.3 Americas Edaravone Injection Sales Growth
4.4 APAC Edaravone Injection Sales Growth
4.5 Europe Edaravone Injection Sales Growth
4.6 Middle East & Africa Edaravone Injection Sales Growth

5 AMERICAS

5.1 Americas Edaravone Injection Sales by Country
  5.1.1 Americas Edaravone Injection Sales by Country (2020-2025)
  5.1.2 Americas Edaravone Injection Revenue by Country (2020-2025)
5.2 Americas Edaravone Injection Sales by Type (2020-2025)
5.3 Americas Edaravone Injection Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Edaravone Injection Sales by Region
  6.1.1 APAC Edaravone Injection Sales by Region (2020-2025)
  6.1.2 APAC Edaravone Injection Revenue by Region (2020-2025)
6.2 APAC Edaravone Injection Sales by Type (2020-2025)
6.3 APAC Edaravone Injection Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Edaravone Injection by Country
  7.1.1 Europe Edaravone Injection Sales by Country (2020-2025)
  7.1.2 Europe Edaravone Injection Revenue by Country (2020-2025)
7.2 Europe Edaravone Injection Sales by Type (2020-2025)
7.3 Europe Edaravone Injection Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Edaravone Injection by Country
  8.1.1 Middle East & Africa Edaravone Injection Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Edaravone Injection Revenue by Country (2020-2025)
8.2 Middle East & Africa Edaravone Injection Sales by Type (2020-2025)
8.3 Middle East & Africa Edaravone Injection Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Edaravone Injection
10.3 Manufacturing Process Analysis of Edaravone Injection
10.4 Industry Chain Structure of Edaravone Injection

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Edaravone Injection Distributors
11.3 Edaravone Injection Customer

12 WORLD FORECAST REVIEW FOR EDARAVONE INJECTION BY GEOGRAPHIC REGION

12.1 Global Edaravone Injection Market Size Forecast by Region
  12.1.1 Global Edaravone Injection Forecast by Region (2026-2031)
  12.1.2 Global Edaravone Injection Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Edaravone Injection Forecast by Type (2026-2031)
12.7 Global Edaravone Injection Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Mitsubishi Tanabe Pharma
  13.1.1 Mitsubishi Tanabe Pharma Company Information
  13.1.2 Mitsubishi Tanabe Pharma Edaravone Injection Product Portfolios and Specifications
  13.1.3 Mitsubishi Tanabe Pharma Edaravone Injection Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Mitsubishi Tanabe Pharma Main Business Overview
  13.1.5 Mitsubishi Tanabe Pharma Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Edaravone Injection Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Edaravone Injection Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of 20ml
Table 4. Major Players of 100ml
Table 5. Global Edaravone Injection Sales by Type (2020-2025) & (K Unit)
Table 6. Global Edaravone Injection Sales Market Share by Type (2020-2025)
Table 7. Global Edaravone Injection Revenue by Type (2020-2025) & ($ million)
Table 8. Global Edaravone Injection Revenue Market Share by Type (2020-2025)
Table 9. Global Edaravone Injection Sale Price by Type (2020-2025) & (USD/Unit)
Table 10. Global Edaravone Injection Sale by Application (2020-2025) & (K Unit)
Table 11. Global Edaravone Injection Sale Market Share by Application (2020-2025)
Table 12. Global Edaravone Injection Revenue by Application (2020-2025) & ($ million)
Table 13. Global Edaravone Injection Revenue Market Share by Application (2020-2025)
Table 14. Global Edaravone Injection Sale Price by Application (2020-2025) & (USD/Unit)
Table 15. Global Edaravone Injection Sales by Company (2020-2025) & (K Unit)
Table 16. Global Edaravone Injection Sales Market Share by Company (2020-2025)
Table 17. Global Edaravone Injection Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Edaravone Injection Revenue Market Share by Company (2020-2025)
Table 19. Global Edaravone Injection Sale Price by Company (2020-2025) & (USD/Unit)
Table 20. Key Manufacturers Edaravone Injection Producing Area Distribution and Sales Area
Table 21. Players Edaravone Injection Products Offered
Table 22. Edaravone Injection Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Edaravone Injection Sales by Geographic Region (2020-2025) & (K Unit)
Table 26. Global Edaravone Injection Sales Market Share Geographic Region (2020-2025)
Table 27. Global Edaravone Injection Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Edaravone Injection Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Edaravone Injection Sales by Country/Region (2020-2025) & (K Unit)
Table 30. Global Edaravone Injection Sales Market Share by Country/Region (2020-2025)
Table 31. Global Edaravone Injection Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Edaravone Injection Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Edaravone Injection Sales by Country (2020-2025) & (K Unit)
Table 34. Americas Edaravone Injection Sales Market Share by Country (2020-2025)
Table 35. Americas Edaravone Injection Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Edaravone Injection Sales by Type (2020-2025) & (K Unit)
Table 37. Americas Edaravone Injection Sales by Application (2020-2025) & (K Unit)
Table 38. APAC Edaravone Injection Sales by Region (2020-2025) & (K Unit)
Table 39. APAC Edaravone Injection Sales Market Share by Region (2020-2025)
Table 40. APAC Edaravone Injection Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Edaravone Injection Sales by Type (2020-2025) & (K Unit)
Table 42. APAC Edaravone Injection Sales by Application (2020-2025) & (K Unit)
Table 43. Europe Edaravone Injection Sales by Country (2020-2025) & (K Unit)
Table 44. Europe Edaravone Injection Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Edaravone Injection Sales by Type (2020-2025) & (K Unit)
Table 46. Europe Edaravone Injection Sales by Application (2020-2025) & (K Unit)
Table 47. Middle East & Africa Edaravone Injection Sales by Country (2020-2025) & (K Unit)
Table 48. Middle East & Africa Edaravone Injection Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Edaravone Injection Sales by Type (2020-2025) & (K Unit)
Table 50. Middle East & Africa Edaravone Injection Sales by Application (2020-2025) & (K Unit)
Table 51. Key Market Drivers & Growth Opportunities of Edaravone Injection
Table 52. Key Market Challenges & Risks of Edaravone Injection
Table 53. Key Industry Trends of Edaravone Injection
Table 54. Edaravone Injection Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Edaravone Injection Distributors List
Table 57. Edaravone Injection Customer List
Table 58. Global Edaravone Injection Sales Forecast by Region (2026-2031) & (K Unit)
Table 59. Global Edaravone Injection Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Edaravone Injection Sales Forecast by Country (2026-2031) & (K Unit)
Table 61. Americas Edaravone Injection Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Edaravone Injection Sales Forecast by Region (2026-2031) & (K Unit)
Table 63. APAC Edaravone Injection Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Edaravone Injection Sales Forecast by Country (2026-2031) & (K Unit)
Table 65. Europe Edaravone Injection Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Edaravone Injection Sales Forecast by Country (2026-2031) & (K Unit)
Table 67. Middle East & Africa Edaravone Injection Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Edaravone Injection Sales Forecast by Type (2026-2031) & (K Unit)
Table 69. Global Edaravone Injection Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Edaravone Injection Sales Forecast by Application (2026-2031) & (K Unit)
Table 71. Global Edaravone Injection Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Mitsubishi Tanabe Pharma Basic Information, Edaravone Injection Manufacturing Base, Sales Area and Its Competitors
Table 73. Mitsubishi Tanabe Pharma Edaravone Injection Product Portfolios and Specifications
Table 74. Mitsubishi Tanabe Pharma Edaravone Injection Sales (K Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Mitsubishi Tanabe Pharma Main Business
Table 76. Mitsubishi Tanabe Pharma Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Edaravone Injection
Figure 2. Edaravone Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Edaravone Injection Sales Growth Rate 2020-2031 (K Unit)
Figure 7. Global Edaravone Injection Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Edaravone Injection Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Edaravone Injection Sales Market Share by Country/Region (2024)
Figure 10. Edaravone Injection Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of 20ml
Figure 12. Product Picture of 100ml
Figure 13. Global Edaravone Injection Sales Market Share by Type in 2025
Figure 14. Global Edaravone Injection Revenue Market Share by Type (2020-2025)
Figure 15. Edaravone Injection Consumed in Hospital
Figure 16. Global Edaravone Injection Market: Hospital (2020-2025) & (K Unit)
Figure 17. Edaravone Injection Consumed in Pharmacy
Figure 18. Global Edaravone Injection Market: Pharmacy (2020-2025) & (K Unit)
Figure 19. Global Edaravone Injection Sale Market Share by Application (2024)
Figure 20. Global Edaravone Injection Revenue Market Share by Application in 2025
Figure 21. Edaravone Injection Sales by Company in 2025 (K Unit)
Figure 22. Global Edaravone Injection Sales Market Share by Company in 2025
Figure 23. Edaravone Injection Revenue by Company in 2025 ($ millions)
Figure 24. Global Edaravone Injection Revenue Market Share by Company in 2025
Figure 25. Global Edaravone Injection Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Edaravone Injection Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Edaravone Injection Sales 2020-2025 (K Unit)
Figure 28. Americas Edaravone Injection Revenue 2020-2025 ($ millions)
Figure 29. APAC Edaravone Injection Sales 2020-2025 (K Unit)
Figure 30. APAC Edaravone Injection Revenue 2020-2025 ($ millions)
Figure 31. Europe Edaravone Injection Sales 2020-2025 (K Unit)
Figure 32. Europe Edaravone Injection Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Edaravone Injection Sales 2020-2025 (K Unit)
Figure 34. Middle East & Africa Edaravone Injection Revenue 2020-2025 ($ millions)
Figure 35. Americas Edaravone Injection Sales Market Share by Country in 2025
Figure 36. Americas Edaravone Injection Revenue Market Share by Country (2020-2025)
Figure 37. Americas Edaravone Injection Sales Market Share by Type (2020-2025)
Figure 38. Americas Edaravone Injection Sales Market Share by Application (2020-2025)
Figure 39. United States Edaravone Injection Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Edaravone Injection Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Edaravone Injection Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Edaravone Injection Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Edaravone Injection Sales Market Share by Region in 2025
Figure 44. APAC Edaravone Injection Revenue Market Share by Region (2020-2025)
Figure 45. APAC Edaravone Injection Sales Market Share by Type (2020-2025)
Figure 46. APAC Edaravone Injection Sales Market Share by Application (2020-2025)
Figure 47. China Edaravone Injection Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Edaravone Injection Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Edaravone Injection Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Edaravone Injection Revenue Growth 2020-2025 ($ millions)
Figure 51. India Edaravone Injection Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Edaravone Injection Revenue Growth 2020-2025 ($ millions)
Figure 53. China Taiwan Edaravone Injection Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Edaravone Injection Sales Market Share by Country in 2025
Figure 55. Europe Edaravone Injection Revenue Market Share by Country (2020-2025)
Figure 56. Europe Edaravone Injection Sales Market Share by Type (2020-2025)
Figure 57. Europe Edaravone Injection Sales Market Share by Application (2020-2025)
Figure 58. Germany Edaravone Injection Revenue Growth 2020-2025 ($ millions)
Figure 59. France Edaravone Injection Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Edaravone Injection Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Edaravone Injection Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Edaravone Injection Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Edaravone Injection Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Edaravone Injection Sales Market Share by Type (2020-2025)
Figure 65. Middle East & Africa Edaravone Injection Sales Market Share by Application (2020-2025)
Figure 66. Egypt Edaravone Injection Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Edaravone Injection Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Edaravone Injection Revenue Growth 2020-2025 ($ millions)
Figure 69. Turkey Edaravone Injection Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Edaravone Injection Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Edaravone Injection in 2025
Figure 72. Manufacturing Process Analysis of Edaravone Injection
Figure 73. Industry Chain Structure of Edaravone Injection
Figure 74. Channels of Distribution
Figure 75. Global Edaravone Injection Sales Market Forecast by Region (2026-2031)
Figure 76. Global Edaravone Injection Revenue Market Share Forecast by Region (2026-2031)
Figure 77. Global Edaravone Injection Sales Market Share Forecast by Type (2026-2031)
Figure 78. Global Edaravone Injection Revenue Market Share Forecast by Type (2026-2031)
Figure 79. Global Edaravone Injection Sales Market Share Forecast by Application (2026-2031)
Figure 80. Global Edaravone Injection Revenue Market Share Forecast by Application (2026-2031)